Medical imaging techniques used for diagnosis, treatment, and monitoring internal body parts, organs, and tissues of small animals is known as small animal imaging.
Major factors driving growth of the global small animal imaging (in-vivo) market are increasing animal healthcare spending, coupled with increasing adoption of advanced molecular imaging equipment. In addition, increasing private and public spending on small animal research is another factor further driving growth of the global market. High cost of installation and operation and stringent government regulations are major factors hampering growth of the global small animal imaging (in-vivo) market.
The global market is segmented on the basis of technology, application, and region. On the basis of technology, the global market is segmented into micro-magnetic resonance imaging, optical imaging, nuclear imaging, ultrasound systems, and others. The optical imaging segment accounts for highest revenue share in the global market; whereas the micro-magnetic resonance imaging segment is expected to witness highest growth over the next 10 years.
On the basis of application, the global market is segmented into monitoring treatment response, bio-distribution, determining drug/target engagement, cancer cell detection, biomarkers, longitudinal studies, and epigenetics. The cancer cell detection segment is expected to witness highest growth over the forecast period.
Request for the Sample Report Here: https://marketresearch.biz/report/small-animal-imaging-in-vivo-market/request-sample/
On the basis of region, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America small animal imaging (in-vivo) market accounts for highest market share in the global market and is expected to maintain its dominance over the forecast period. The Europe market accounts for second highest share in the global market in terms of revenue. The Asia Pacific small animal imaging (in-vivo) market is expected to witness highest growth during the forecast period.
Key players in the global market are Promega Corporation, Inc., Miltenyi Biotec GmbH, Life Technologies Corporation, FujiFilm Holding Corporation, Siemens AG, Trifoil Imaging, Thermo Fisher Scientific, Bruker Corporation, PerkinElmer Inc., Aspect Imaging Ltd., and other prominent players.